Fractionated photodynamic therapy for a human oral squamous cell carcinoma xenograft

Oral Oncology

Volumn 42, Issue 5, 2006, Pages 526-532

  Togashi, Hiroaki ^a   Uehara, Masataka ^a   Ikeda, Hisazumi ^a   Inokuchi, Tsugio ^a  

^a Reconstruction and Functional Restoration   (Japan)

Author keywords

Fractionation; Photodynamic therapy; Vascular endothelial growth factor

Indexed keywords

CYCLINE; VASCULOTROPIN;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASE REPORT; CELL PROLIFERATION; CELL SURVIVAL; COMPUTER AIDED DESIGN; CONTROLLED STUDY; EVALUATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER; LIGHT EXPOSURE; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REOXYGENATION; SQUAMOUS CELL CARCINOMA; TIME; TUMOR CELL; TUMOR VOLUME; XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; DOSE FRACTIONATION; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; MOUTH NEOPLASMS; NECROSIS; NEOPLASM TRANSPLANTATION; PHOTOCHEMOTHERAPY; PROLIFERATING CELL NUCLEAR ANTIGEN; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33646472931     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2005.10.006     Document Type: Article

References (26)

1. Dougherty T.J., Gomer C.J., Henderson B.W., et al. Photodynamic therapy. J Natl Cancer Inst 90 (1998) 889-905
2. Uehara M., Inokuchi T., and Sano K. Experimental study of combined hyperthermic and photodynamic therapy on carcinoma in the mouse. J Oral Maxillofac Surg 54 (1996) 729-736 discussion 36-7
3. Uehara M., Sano K., Wang Z.L., Sekine J., Ikeda H., and Inokuchi T. Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinoma. Cancer Immunol Immunother 49 (2000) 401-409
4. Uehara M., and Inokuchi T. Hyperthermic photodynamic therapy combined with topical administration of OK-432 in the mouse carcinoma. Oral Oncol 39 (2003) 184-189
5. Uehara M, Inokuchi T, Ikeda H. Enhanced susceptibility of mouse squamous cell carcinoma to photodynamic therapy combined with low dose administration of cisplatin. J Oral Maxillofac Surg, in press.
6. Herzog M., Moser J., Wagner B., and Broecker J. Shielding effects and hypoxia in photodynamic therapy. Int J Oral Maxillofac Surg 23 (1994) 406-408
7. Henderson B.W., and Fingar V.H. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res 47 (1987) 3110-3114
8. Tomaselli F., Maier A., Sankin O., et al. Acute effects of combined photodynamic therapy and hyperbaric oxygenation in lung cancer-a clinical pilot study. Lasers Surg Med 28 (2001) 399-403
9. Maier A., Tomaselli F., Anegg U., et al. Combined photodynamic therapy and hyperbaric oxygenation in carcinoma of the esophagus and the esophago-gastric junction. Eur J Cardiothorac Surg 18 (2000) 649-654 discussion 54-5
10. Maier A., Anegg U., Fell B., et al. Hyperbaric oxygen and photodynamic therapy in the treatment of advanced carcinoma of the cardia and the esophagus. Lasers Surg Med 26 (2000) 308-315
11. Pe M.B., Ikeda H., and Inokuchi T. Tumour destruction and proliferation kinetics following periodic, low power light, haematoporphyrin oligomers mediated photodynamic therapy in the mouse tongue. Eur J Cancer B Oral Oncol 30B (1994) 174-178
12. Foster T.H., Murant R.S., Bryant R.G., Knox R.S., Gibson S.L., and Hilf R. Oxygen consumption and diffusion effects in photodynamic therapy. Radiat Res 126 (1991) 296-303
13. Messmann H., Mlkvy P., Buonaccorsi G., Davies C.L., MacRobert A.J., and Bown S.G. Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies. Br J Cancer 72 (1995) 589-594
14. de Bruijn H.S., van der Veen N., Robinson D.J., and Star W.M. Improvement of systemic 5-aminolevulinic acid-based photodynamic therapy in vivo using light fractionation with a 75-minute interval. Cancer Res 59 (1999) 901-904
15. van der Veen N., van Leengoed H.L., and Star W.M. In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. Br J Cancer 70 (1994) 867-872
16. Gibson S.L., VanDerMeid K.R., Murant R.S., Raubertas R.F., and Hilf R. Effects of various photoradiation regimens on the antitumor efficacy of photodynamic therapy for R3230AC mammary carcinomas. Cancer Res 50 (1990) 7236-7241
17. Uehara M., Inokuchi T., Sano K., and ZuoLin W. Expression of vascular endothelial growth factor in mouse tumours subjected to photodynamic therapy. Eur J Cancer 37 (2001) 2111-2115
18. Leung D.W., Cachianes G., Kuang W.J., Goeddel D.V., and Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246 (1989) 1306-1309
19. Ferrario A., von Tiehl K.F., Rucker N., Schwarz M.A., Gill P.S., and Gomer C.J. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res 60 (2000) 4066-4069
20. Pal S., Datta K., and Mukhopadhyay D. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma. Cancer Res 61 (2001) 6952-6957
21. Fujisawa A., Ikeda H., Tobita T., and Inokuchi T. Establishment and Characterization of Human Oral Squamous Cell Carcinoma Cell Lines. Oral Med Pathol 9 (2004) 133-139
22. Uehara M., Inokuchi T., Sano K., Sekine J., and Ikeda H. Cell kinetics of mouse tumour subjected to photodynamic therapy-evaluation by proliferating cell nuclear antigen immunohistochemistry. Oral Oncol 35 (1999) 93-97
23. Wu L.C., D'Amelio F., Fox R.A., Polyakov I., and Daunton N.G. Light microscopic image analysis system to quantify immunoreactive terminal area apposed to nerve cells. J Neurosci Methods 74 (1997) 89-96
24. Moan J., and Sommer S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res 45 (1985) 1608-1610
25. Shweiki D., Itin A., Soffer D., and Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359 (1992) 843-845
26. Eyssen-Hernandez R., Ladoux A., and Frelin C. Differential regulation of cardiac heme oxygenase-1 and vascular endothelial growth factor mRNA expressions by hemin, heavy metals, heat shock and anoxia. FEBS Lett 382 (1996) 229-233